Repligen COO Sells $331k in RGEN Stock
REPLIGEN CORP
Subscribe to track RGEN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Repligen COO Sells $331k in RGEN Stock
Company: REPLIGEN CORP (RGEN) Form: 4 | Filed: 2025-11-19 Significance: Low
Insider: Bylund James Title: Chief Operating Officer | Relationship: Officer
Transaction: • Type: Sale • Shares: 2,191 • Price: $151.21 • Value: $331,259 • Owned After: 21,520
Key Insight: The transaction is of low significance, representing less than 0.01% of the company's market cap and shares outstanding. The sale constitutes approximately 9.2% of the insider's direct holdings.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: REPLIGEN CORP (RGEN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chief Operating Officer, James Bylund, sold 2,191 shares of common stock for a total value of approximately $331,259.
- Market Impact: This transaction is considered routine and is unlikely to have a material impact on the stock price due to its small size relative to the company's market capitalization.
Company Information
| Field | Value |
|---|---|
| Company | REPLIGEN CORP |
| Ticker Symbol | RGEN |
| CIK | 0000730272 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Bylund James |
| CIK | 0001849642 |
| Title/Position | Chief Operating Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-18 |
| Transaction Code | S (Sale) |
| Security Type | Common Stock |
| Shares Involved | 2,191 |
| Price Per Share | $151.21 (Weighted Average) |
| Total Value | $331,259.11 |
| Shares Owned After | 21,520 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $331,259.11 |
| % of Market Cap | 0.0039% |
| Shares Transacted | 2,191 |
| % of Shares Outstanding | 0.0039% |
| Post-Transaction Ownership | 21,520 shares (0.038% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Repligen has a market capitalization of $8.58 billion. This $331k sale is negligible in comparison, representing a tiny fraction of the company's total value.
- Ownership Concentration: The COO's post-transaction holding of 21,520 shares represents a very small portion (0.038%) of the total shares outstanding, indicating low ownership concentration from this insider.
- Transaction Significance: The sale represents approximately 9.2% of the insider's direct holdings. While not a trivial amount for the individual, it is immaterial from a market perspective, falling well below the thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction size is too small relative to the company's market cap and daily trading volume to influence investor sentiment or stock price.
Volume & Sentiment
- Expected Volume Impact: Negligible. The transaction is unlikely to cause any noticeable change in trading volume.
- Sentiment Indicator: Neutral. This is a routine insider sale, likely for personal financial planning, and does not signal a change in the company's outlook.
Additional Context
Transaction Notes
- Special Circumstances: The sale price of $151.21 is a weighted average, with shares sold in multiple transactions ranging from $151.21 to $151.62. This is a common practice for executing orders to minimize market impact.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
